Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Riegel v. Medtronic At Supreme Court: Common Law Against Federal Statute

This article was originally published in The Gray Sheet

Executive Summary

A major case impacting the medical device industry's vulnerability to product liability suits will land in the U.S. Supreme Court next month and legal scholars predict the outcome will be a close call

You may also be interested in...



In Victory For Device Industry, Supreme Court Favors PMA Pre-emption

In a ruling that is expected to shave the volume of lawsuits against device manufacturers, the Supreme Court held that FDA premarket approval should preclude patients from suing companies for personal injury in most cases

In Victory For Device Industry, Supreme Court Favors PMA Pre-emption

In a ruling that is expected to shave the volume of lawsuits against device manufacturers, the Supreme Court held that FDA premarket approval should preclude patients from suing companies for personal injury in most cases

Supreme Court Majority Appears To Support PMA Pre-emption Defense

A majority of Supreme Court justices appeared to support some measure of federal PMA pre-emption over state liability claims during Dec. 4 oral arguments in the case of Riegel v. Medtronic, according to court watchers. But they say the ruling might include some caveats

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel